143 related articles for article (PubMed ID: 35385719)
1. Optimization of Cyclic Peptide Property Using Chromatographic Capacity Factor on Permeability of Passive Cell Membrane and Human Induced Pluripotent Stem Cell-Derived Intestinal Membrane.
Watanabe A; Uehara S; Akazawa T; Fujiu M
J Pharm Sci; 2022 Jul; 111(7):1879-1886. PubMed ID: 35385719
[TBL] [Abstract][Full Text] [Related]
2. Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility.
Naylor MR; Ly AM; Handford MJ; Ramos DP; Pye CR; Furukawa A; Klein VG; Noland RP; Edmondson Q; Turmon AC; Hewitt WM; Schwochert J; Townsend CE; Kelly CN; Blanco MJ; Lokey RS
J Med Chem; 2018 Dec; 61(24):11169-11182. PubMed ID: 30395703
[TBL] [Abstract][Full Text] [Related]
3. Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes.
Ermondi G; Vallaro M; Camacho-Leal MP; Potter T; Visentin S; Caron G
Eur J Pharm Sci; 2018 Sep; 122():85-93. PubMed ID: 29935350
[TBL] [Abstract][Full Text] [Related]
4. Effect of Flexibility, Lipophilicity, and the Location of Polar Residues on the Passive Membrane Permeability of a Series of Cyclic Decapeptides.
Wang S; König G; Roth HJ; Fouché M; Rodde S; Riniker S
J Med Chem; 2021 Sep; 64(17):12761-12773. PubMed ID: 34406766
[TBL] [Abstract][Full Text] [Related]
5. Lipophilic and polar interaction forces between acidic drugs and membrane phospholipids encoded in IAM-HPLC indexes: their role in membrane partition and relationships with BBB permeation data.
Grumetto L; Carpentiero C; Di Vaio P; Frecentese F; Barbato F
J Pharm Biomed Anal; 2013 Mar; 75():165-72. PubMed ID: 23261809
[TBL] [Abstract][Full Text] [Related]
6. Lipophilic and electrostatic forces encoded in IAM-HPLC indexes of basic drugs: their role in membrane partition and their relationships with BBB passage data.
Grumetto L; Carpentiero C; Barbato F
Eur J Pharm Sci; 2012 Apr; 45(5):685-92. PubMed ID: 22306648
[TBL] [Abstract][Full Text] [Related]
7. CycPeptMPDB: A Comprehensive Database of Membrane Permeability of Cyclic Peptides.
Li J; Yanagisawa K; Sugita M; Fujie T; Ohue M; Akiyama Y
J Chem Inf Model; 2023 Apr; 63(7):2240-2250. PubMed ID: 36930969
[TBL] [Abstract][Full Text] [Related]
8. Enantiomeric cyclic peptides with different Caco-2 permeability suggest carrier-mediated transport.
Marelli UK; Bezençon J; Puig E; Ernst B; Kessler H
Chemistry; 2015 May; 21(22):8023-7. PubMed ID: 25917866
[TBL] [Abstract][Full Text] [Related]
9. Gaussian accelerated molecular dynamics simulations facilitate prediction of the permeability of cyclic peptides.
Frazee N; Billlings KR; Mertz B
PLoS One; 2024; 19(4):e0300688. PubMed ID: 38652734
[TBL] [Abstract][Full Text] [Related]
10. Passing the Barrier - How Computer Simulations Can Help to Understand and Improve the Passive Membrane Permeability of Cyclic Peptides.
Linker SM; Wang S; Ries B; Stadelmann T; Riniker S
Chimia (Aarau); 2021 Jun; 75(6):518-521. PubMed ID: 34233816
[TBL] [Abstract][Full Text] [Related]
11. Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry.
Furukawa A; Townsend CE; Schwochert J; Pye CR; Bednarek MA; Lokey RS
J Med Chem; 2016 Oct; 59(20):9503-9512. PubMed ID: 27690434
[TBL] [Abstract][Full Text] [Related]
12. A correlation for 1,9-decadiene/water partition coefficients.
Nitsche JM; Kasting GB
J Pharm Sci; 2013 Jan; 102(1):136-44. PubMed ID: 23132301
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical determinants of passive membrane permeability: role of solute hydrogen-bonding potential and volume.
Goodwin JT; Conradi RA; Ho NF; Burton PS
J Med Chem; 2001 Oct; 44(22):3721-9. PubMed ID: 11606137
[TBL] [Abstract][Full Text] [Related]
14. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
15. Relationship between immobilized artificial membrane chromatographic retention and human oral absorption of structurally diverse drugs.
Kotecha J; Shah S; Rathod I; Subbaiah G
Int J Pharm; 2007 Mar; 333(1-2):127-35. PubMed ID: 17095172
[TBL] [Abstract][Full Text] [Related]
16. Reversed-phase high-performance liquid chromatography for evaluating the distribution of pharmaceutical substances in suppository base-phosphate buffer system.
Dimitrova B; Doytchinova I; Zlatkova M
J Pharm Biomed Anal; 2000 Nov; 23(6):955-64. PubMed ID: 11095296
[TBL] [Abstract][Full Text] [Related]
17. Membrane permeability related physicochemical properties of a novel gamma-secretase inhibitor.
El-Gendy AM; Adejare A
Int J Pharm; 2004 Aug; 280(1-2):47-55. PubMed ID: 15265546
[TBL] [Abstract][Full Text] [Related]
18. Rationalization of the Membrane Permeability Differences in a Series of Analogue Cyclic Decapeptides.
Witek J; Wang S; Schroeder B; Lingwood R; Dounas A; Roth HJ; Fouché M; Blatter M; Lemke O; Keller B; Riniker S
J Chem Inf Model; 2019 Jan; 59(1):294-308. PubMed ID: 30457855
[TBL] [Abstract][Full Text] [Related]
19. Beyond cyclosporine A: conformation-dependent passive membrane permeabilities of cyclic peptide natural products.
Ahlbach CL; Lexa KW; Bockus AT; Chen V; Crews P; Jacobson MP; Lokey RS
Future Med Chem; 2015; 7(16):2121-30. PubMed ID: 26067057
[TBL] [Abstract][Full Text] [Related]
20. Determination of lipophilic descriptors of antihelmintic 6,7-diaryl-pteridine derivatives useful for bioactivity predictions.
Reta M; Giacomelli L; Santo M; Cattana R; Silber JJ; Ochoa C; Rodriguez M; Chana A
Biomed Chromatogr; 2003 Sep; 17(6):365-72. PubMed ID: 13680846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
